Related Experiment Videos
Targeting gene expression in the preimplantation mouse embryo using morpholino antisense oligonucleotides
Laura S Siddall1, Lisa C Barcroft, Andrew J Watson
1Department of Obstetrics and Gynaecology, The University of Western Ontario, Rm 238, Medical Science Building, London, Ontario, Canada.
Molecular Reproduction and Development
|November 2, 2002
Summary
Morpholino antisense oligonucleotides effectively down-regulate gene expression in early mammalian embryos. Researchers optimized conditions for using these morpholino oligonucleotides (MOs) to study gene function during preimplantation development.
Area of Science:
- Developmental Biology
- Molecular Biology
- Genetics
Background:
- Morpholino antisense oligonucleotides (MOs) are established tools for gene silencing by inhibiting translation.
- Their application in mammalian preimplantation embryos requires defined treatment conditions for effective gene down-regulation.
Purpose of the Study:
- To establish optimal treatment parameters for MOs in murine preimplantation embryos.
- To utilize MOs for targeting specific genes and investigating their function in early embryonic development.
Main Methods:
- Investigated MO delivery using ethoxylated polyethylenimine (EPEI), Lipofectin, and Lysolecithin.
- Tested MO concentrations (1-20 microM) and treatment durations (3-48 hr) on two- and eight-cell stage murine embryos.
- Employed a fluorescent control MO and an alpha-catenin specific MO.
Main Results:
- Continuous treatment with Lipofectin and 20 microM alpha-catenin MO for 48 hr significantly reduced blastocyst development (P < 0.05).
- A marked reduction in alpha-catenin protein levels was observed under these conditions.
- Demonstrated the efficacy of MOs in down-regulating gene expression during murine preimplantation development.
Conclusions:
- Morpholino antisense oligonucleotides are effective for down-regulating gene expression in mammalian preimplantation embryos.
- Optimized delivery methods and treatment conditions are crucial for successful MO application in early development research.